Cohort Company News - MedTech Innovator

Israeli AI FemTech solution secures prestigious US cancer grant of $2.3M to advance women’s health (featuring MobileODT)

DateJan 25 2021

MobileODT, an Israeli FemTech startup focusing on AI-powered cervical screening, has caught the eye of the US National Cancer Institute (NCI), with the NCI awarding Mobile ODT with a $2.3 million grant. The Small Business Innovation Research Authority grant is given by the NCI to companies that are technologically and clinically reducing the suffering from cancer.

Harvard spin-off CELLVIE closes $5M seed round in pursuit of a new treatment modality: therapeutic mitochondria transfer

DateJan 25 2021

cellvie Inc., the leader in Therapeutic Mitochondria Transfer (TMT) and a Harvard University spin-off, closes a $5M round to advance its product pipeline, including a first application in rejuvenation.

Lightpoint’s SENSEI robotic gamma probe gains CE mark for sentinel lymph node detection

DateJan 20 2021

Lightpoint Medical announced Wednesday that its SENSEI robotic gamma probe received the CE mark for intra-operative detection of sentinel lymph nodes. The company said the approval makes SENSEI the first robotic gamma probe to be commercially available to hospitals in Europe.

Hillrom Announces Planned Acquisition Of Bardy Diagnostics, Inc.

DateJan 19 2021

Hillrom today announced it has reached a definitive agreement to acquire Bardy Diagnostics, Inc. (BardyDx), an innovator in digital health and a leading provider of ambulatory cardiac monitoring technologies.

BIRD – Israel-U.S. Binational Industrial R&D Foundation to Invest $7.45M in Eight New Projects, featuring Donisi Health

DateJan 19 2021

During its meeting on December 22, 2020, held via video conference, the Board of Governors of the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation approved $7.45 million in funding for eight new projects between U.S. and Israeli companies.

HealthyU’s 7 lead ECG makes it easier to monitor patients remotely

DateJan 14 2021

HD medical is hoping to bridge the gap between your home and the doctor's office with HealthyU, a little device that measures your vital signs remotely and feeds them directly to your medical provider.

GTT Group’s Patent Equity Fund Ideaship Invests in 8chili to Deploy Revolutionary Surgical Technology to Build the Foundation for Autonomous Surgeries

DateJan 14 2021

Ideaship, a patent leveraged venture capital firm that provides patent development support to early-stage startups, announced it has invested in 8chili, Inc. The investment will assist 8chili’s mission to reimagine surgical training and surgeries with 8chili’s patent pending device, NAVIX AIR.

Koya Medical Closes $11M Financing to Accelerate Treatment for Lymphedema and Venous Disorders

DateJan 14 2021

Koya Medical (www.koyamedical.com), a healthcare company focused on treating lymphedema and vein disease, today announced the close of a $11 million Series A investment round. The new investment was led by Arboretum Ventures.

Promaxo Raises $4.17M in Funding Round Led by Huami Corporation

DateJan 13 2021

. Promaxo’s patient-centric approach will provide patients with cutting-edge technology as it works to expand the frontiers of knowledge in the fields of medical imaging, robotics, and artificial intelligence.

Itamar Medical acquires Spry Health to improve remote sleep apnea treatment

DateJan 13 2021

Leading Israeli sleep apnea digital health company Itamar Medical has announced its acquisition of Spry Health in a bid to expand its product offerings into remote monitoring and support for the condition.

Novus Diagnostics gets €2.4M grant for rapid sepsis test

DateJan 12 2021

Irish company Novus Diagnostics has been awarded €2.4 million in funding to commercialise its rapid sepsis test. The only Irish company to be awarded funding from this round of the European Innovation Council (EIC) Accelerator pilot, DCU-based Novus Diagnostics has been working in collaboration with two Dublin hospitals on validating the SepTec diagnostic device.

NEUROFLOW closes $20M Series B Investment

DateJan 12 2021

NeuroFlow, the market leader in solutions supporting technology-enabled behavioral health integration, announces today the initial closing of a $20M Series B financing round led by Magellan Health (NASDAQ: MGLN), in addition to a syndicate including previous investors.

Rhaeos: Greater Insight for Hydrocephalus Solutions

DateJan 07 2021

The shunts that relieve fluid pressure in the brain are failure-prone, but current imaging methods don’t provide enough data to assess their function. Rhaeos is seeking to fill that gap with a wearable flow monitor that yields insightful data in minutes.

CathWorks Announces $30M in New Financing

DateJan 07 2021

CathWorks reported the completion of a $30 million Series D financing round. Proceeds from the financing will be used to expand commercialization of the company's FFRangio system.

Avisi closed an oversubscribed Seed round

DateJan 05 2021

These funds will be instrumental in advancing #VisiPlate to clinical trials, growing our team, and taking us one step closer to helping tens of millions of patients preserve their vision.

How artificial intelligence and augmented reality are changing medical proctoring during COVID-19 (featuring ExplORer Surgical)

DateJan 04 2021

Launched out of the University of Chicago Department of Surgery in 2013, ExplORer recently added augmented reality technology that acts as a virtual laser pointer for medical device specialists to provide on-screen guidance for surgeons similarly to how sports announcers use a Telestrator to mark up plays.

Vancouver-based Stoko creates products for ‘athletes of all abilities’

DateJan 04 2021

Formerly known as Embrace Orthopaedics, the Vancouver-based brand Stoko merges “functional support and activewear” for athletes. For the company, that means creating a Health Canada-registered knee support in innovative athletic tights.

Mitochondrial Transplantation to Treat Ischemia-Reperfusion Injury: Interview with Dr. Alexander Schueller, CEO of cellvie

DateDec 22 2020

cellvie, a company based in Houston, Texas, is developing a mitochondrial transplantation therapy to help reduce the damage caused by ischemia-reperfusion injury.

Strados Labs receives FDA 510(k) clearance for its wireless lung sound measurement platform, RESP™

DateDec 22 2020

Strados Labs, a health technology developer of remote respiratory devices and software, today announced it has received FDA Class II 510(k) clearance for its first product, RESP™, a system for measuring, recording and analyzing lung sounds remotely across healthcare settings.

Onkos Surgical® continues its innovation in musculoskeletal oncology and complex orthopaedic reconstruction with the launch of the ELEOS™ Proximal Tibia with BioGrip™ technology

DateDec 21 2020

Onkos Surgical, Inc., an innovator in the field of musculoskeletal oncology and personalized orthopaedics, continues to deliver on its promise of commercializing innovative solutions with the launch of the new ELEOS Proximal Tibia with BioGrip technology.